Inside informationEnglish
Biophytis enters strategic agreement in Asia and secures $20 million for launch of Phase 3 trial in sarcopenia
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Biophytis
- Filed
- 28/01/2026, 07:29
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 080791_20260128